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Abstract Pin2/TRF1 was independently identified as a telo-
meric DNA-binding protein (TRF1) that regulates telomere
length, and as a protein (Pin2) that can bind the mitotic kinase
NIMA and suppress its lethal phenotype. We have previously
demonstrated that Pin2/TRF1 levels are cell cycle-regulated and
its overexpression induces mitotic arrest and then apoptosis. This
Pin2/TRF1 activity can be potentiated by microtubule-disrupting
agents, but suppressed by phosphorylation of Pin2/TRF1 by
ATM; this negative regulation is critical in mediating for many,
but not all, ATM-dependent phenotypes. Interestingly, Pin2/
TRF1 specifically localizes to mitotic spindles in mitotic cells and
affects the microtubule polymerization in vitro. These results
suggest a role of Pin2/TRF1 in mitosis. However, nothing is
known about whether Pin2/TRF1 affects the spindle function in
mitotic progression. Here we characterized a new Pin2/TRF1-
interacting protein, EB1, that was originally identified in our
yeast two-hybrid screen. Pin2/TRF1 bound EB1 both in vitro and
in vivo and they also co-localize at the mitotic spindle in cells.
Furthermore, EB1 inhibits the ability of Pin2/TRF1 to promote
microtubule polymerization in vitro. Given that EB1 is a
microtubule plus end-binding protein, these results further
confirm a specific interaction between Pin2/TRF1 and the
mitotic spindle. More importantly, we have shown that in-
hibition of Pin2/TRF1 in ataxia^telangiectasia cells is able to
fully restore their mitotic spindle defect in response to
microtubule disruption, demonstrating for the first time a
functional involvement of Pin2/TRF1 in mitotic spindle
regulation. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: ATM; Pin2/TRF1; Microtubule;
Mitotic spindle checkpoint; Telomere
1. Introduction
Telomeres are essential for preserving chromosome integrity
during cell division. Telomeres are composed of repetitive
DNA sequences of TTAGGG arrays concealed by a complex
of telomeric proteins that protects the ends from exonucleo-
lytic attack, fusion and incomplete replication [1^5]. An in-
creasing body of evidence links telomeres to mitotic progres-
sion. For example, deletion of telomeres triggers mitotic arrest
and apoptosis in Drosophila [6]. In ¢ssion yeast, telomeres are
clustered at the nuclear periphery in G2, but this association is
disrupted in mitosis [7], and telomeres have been shown to
mediate the attachment of chromosomes to spindle bodies and
lead chromosome movement in meiotic prophase [8]. In bud-
ding yeast, mutations in the related TEL1 and MEC1 genes
result in shortened telomeres, G2/M checkpoint defect and
genomic instability [9,10]. Similarly, mutations in its human
counterpart, the ATM gene, cause ataxia^telangiectasia (A-T)
both in humans and mice, displaying a wide range of abnor-
malities, including those related to telomere dysfunction [11^
15]. More interestingly, cell lines derived from A-T patients
have shortened telomere lengths [16^18] and defective mitotic
checkpoints [19,20]. Finally, mutations in the Tetrahymena
telomeric DNA sequence have been shown to cause a block
in anaphase chromosome separation [21]. Collectively, these
results suggest that telomeres may be important for regulation
of mitosis. However, little is known about the identity and
function of the signaling molecule(s) involved in this process.
In our e¡ort to understand molecular mechanisms of mi-
totic regulation, we previously isolated three human proteins,
Pin1^3, that physically and functionally interact with NIMA,
an essential mitotic kinase in Aspergillus nidulans [22,23].
Characterization of these Pin proteins shows that they are
all involved in mitotic regulation [24]. Pin1 binds and regu-
lates the function of a subset of phosphoproteins by control-
ling the conformation of speci¢c phosphorylated Ser/Thr^Pro
motifs [25^29]. Pin2 is identical in the sequence to TRF1 apart
from an internal deletion of 20 amino acids [30]. TRF1 is a
double strand DNA-binding protein that negatively regulates
telomere elongation [31,32]. Pin2 and TRF1 are likely to be
two alternatively spliced isoforms of the same gene PIN2/
TRF1, as suggested by Young et al. [33]. However, we have
shown that Pin2 is 5^10-fold more abundant than TRF1 in
the cells and the expression level of Pin2/TRF1 is tightly regu-
lated during the cell cycle [30]. Both Pin2 and TRF1 contain a
D-like motif similar to the destruction box present in many
mitotic proteins, and their protein levels are signi¢cantly in-
creased in late G2 and mitosis and then degraded as cells exit
from mitosis [30]. Furthermore, overexpression of Pin2/TRF1
induces abortive mitosis and apoptosis in cells containing
short telomeres [34]. Moreover, Pin2/TRF1 is an ATM kinase
substrate and inhibition of Pin2/TRF1 by ATM plays a crit-
ical role in ATM-dependent regulation of telomere mainte-
nance, the radiosensitivity and G2/M checkpoint regulation
[35,36]. Interestingly, the localization of Pin2/TRF1 is regu-
lated during the cell cycle; Pin2/TRF1 speci¢cally localizes to
mitotic spindles in mitotic cells [37]. These results indicate that
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Pin2/TRF1 has a speci¢c function in mitotic regulation. How-
ever, little is known about how Pin2/TRF1 is involved in
mitotic progression and whether Pin2/TRF1 a¡ects the micro-
tubule function in mitotic cells.
As part of our e¡ort to further elucidate how Pin2/TRF1 is
involved in regulation of telomeres and mitotic regulation, we
have recently employed a yeast two-hybrid screen and identi-
¢ed six known genes and four unknown PinX1^4 genes,
whose products interact with this protein [38]. Characteriza-
tion of PinX1 reveals that it is a potent catalytic inhibitor of
telomerase and a putative tumor suppressor [38]. These results
further support a negative role of Pin2/TRF1 in telomere
regulation and the role of telomerase in oncogenesis.
One known gene identi¢ed in our Pin2/TRF1 two-hybrid
screen is EB1. Human EB1 interacts with the tumor suppres-
sor APC in a cell cycle-dependent manner [39^41]. This inter-
action targets APC to the microtubule distal tips [42,43] and is
critical for promoting microtubule assembly [44]. The EB1
homologues Mal3 and BIM1 in both budding and ¢ssion
yeast, respectively, have also been shown to promote micro-
tubule assembly [41,45,46]. Finally, Bim1p is involved in reg-
ulation of the late mitotic checkpoint [47]. Mutation of BIM1
abolishes the delay following improper separation of chromo-
somes, resulting in multinucleated cells. Because aneuploidy is
often observed in colon cancer cells [48], the late mitotic
checkpoint has been proposed to be responsible for the tumor
suppressive e¡ect of APC [49].
Here we characterized interaction of Pin2/TRF1 and EB1
and examined the functional signi¢cance of Pin2/TRF1 in
mitotic spindle regulation in vivo. Pin2/TRF1 bound EB1
both in vitro and in vivo and they also co-localize at the
mitotic spindle in cells. Furthermore, EB1 inhibits the ability
of Pin2/TRF1 to promote microtubule polymerization in vi-
tro. Moreover, we have shown that inhibition of Pin2/TRF1
in A-T cells is able to fully restore their mitotic spindle defect
in response to microtubule disruption. These results con¢rm a
speci¢c interaction between Pin2/TRF1 and the mitotic spin-
dle, and more importantly demonstrate for the ¢rst time a
functional involvement of Pin2/TRF1 in mitotic spindle regu-
lation.
2. Materials and methods
2.1. DNA construction
Various GFP-Pin2 constructs were described previously [34]. To
construct GFP-Pin2300ÿ419, GFP-Pin2 plasmid was digested by EcoRI
and XmnI, followed by self-ligation. Various GST fusion proteins
were expressed in bacteria and puri¢ed, as described [29].
2.2. Fluorescence microscopy
Fluorescence microscopy was performed, as described previously
[37,44]. Brie£y, HeLa cells were transfected by pEGFP and RFP-
EB1 constructs and ¢xed with methanol, subjected to £uorescence
microscopy.
2.3. Microtubule polymerization assays
Microtubule assembly assay was performed, as described [28,37,44].
Brie£y, 0.77 WM of various recombinant proteins was incubated with
13 WM of puri¢ed bovine tubulin (cytoskeleton) in 20 Wl of micro-
tubule stabilizing bu¡er containing 1 mM GTP, 1 mM MgCl2 and
10% glycerol at 30‡C, followed by measuring changes in turbidity
every 6 s.
2.4. Stable expression of ATM or Pin2 mutants in A-T cells
For stable expression of ATM, pEBS7 vector encoding full length
ATM tagged with FLAG or the control vector were stably transfected
into parental A-T22IJE-T cells, as described [50]. A-T22IJE-T cells
were originally derived from primary ACT ¢broblasts, which harbor
a homozygous frameshift mutation at codon 762 of the ATM gene
and contain no ATM protein since the truncated protein is not stable
[50^52]. After selection with hygromycin B (200 Wg/ml) and limiting
dilution, multiple clones were isolated and checked for ATM expres-
sion by immunoblotting analysis with anti-ATM antibody (Ab-3) and
anti-FLAG antibody (M5). For stable expression of the Pin2 mutant,
cDNA encoding Pin21ÿ316 was cloned into the pEGFP-C1 vector and
stably transfected into A-T22IJE-T cells. After selection with G418
(1 mg/ml), GFP-expressed cells were picked up under £uorescence
microscopy. Multiple stable clones were obtained with similar proper-
ties.
2.5. Cell cycle analysis
To examine the e¡ects on the mitotic spindle checkpoint, cells were
incubated with 100 ng/ml Nocodazole for 16^20 h and harvested,
¢xed and stained by propidium iodide (0.01 mg/ml) containing 0.25
mg/ml of RNase, followed by £ow cytometrical analysis (Becton-
Dickinson), as described [34,35].
2.6. Histone H1 kinase assay
Histone kinase assay was performed as described previously [22].
Brie£y, cell extracts were incubated with 200 WM [Q-32P]ATP and 2.5
Wg histone H1 at 23‡C for 10 min and the reaction was stopped by
addition of SDS sample bu¡er, followed by SDS^PAGE and auto-
radiography.
3. Results and discussion
3.1. Pin2/TRF1 interacts with EB1 in vitro and in vivo
In our search for Pin2/TRF1-binding proteins by two-hy-
brid screening of a HeLa cDNA library [38], we identi¢ed
three independent clones encoding EB1. GST pulldown was
used to con¢rm their direct interaction in vitro. [35S]Pin2 was
generated by in vitro transcription and translation, followed
by GST pulldown assay with puri¢ed GST-EB1. Although
there was no binding between GST and Pin2, GST-EB1 read-
ily bound Pin2 (Fig. 1a). To examine whether EB1 binds
cellular Pin2/TRF1, lysate of HCT116 human colon cancer
cells containing wild-type APC was subjected to the GST-
EB1 pulldown assay. As expected, APC was precipitated by
EB1 (Fig. 1b). More importantly, endogenous Pin2/TRF1 was
also precipitated by EB1, but not by GST (Fig. 1b). Finally,
to examine whether EB1 and Pin2 form a stable complex in
cells, HA-Pin2/TRF1 and FLAG-EB1 constructs were co-
transfected into HeLa cells. Then their lysate was subjected
to immunoprecipitation with anti-FLAG monoclonal anti-
body (mAb), followed by immunoblotting with anti-FLAG
(EB1) and anti-HA (Pin2/TRF1) mAbs. As shown in Fig.
1c, Pin2 was co-precipitated with EB1. These results demon-
strate that EB1 interacts with Pin2/TRF1 both in vivo and in
vitro.
3.2. Pin2/TRF1 co-localizes with EB1 at the mitotic spindle
To further con¢rm the in vivo interaction between Pin2/
TRF1 and EB1, we co-transfected GFP-Pin2 and RFP-EB1
constructs into HeLa cells and examined their localization
during the cell cycle using £uorescence microscopy. As shown
previously [37], Pin2/TRF1 binds microtubules and localized
to the mitotic spindle only in mitotic cells (Fig. 2). Interest-
ingly, GFP-Pin2 and RFP-EB1 co-localized in mitotic spin-
dles only in these mitotic cells (Fig. 2), but not in interphase
cells (data not shown). These results indicate that Pin2/TRF1
and EB1 not only bind, but also co-localize at the mitotic
spindle in the cell.
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Fig. 1. EB1 binds Pin2/TRF1 in vitro and in vivo. a: GST-EB1 pulldown with translated [35S]Pin2/TRF1. [35S]Pin2/TRF1 was produced and
incubated with interphase or mitotic Xenopus extracts followed by incubation with glutathione beads containing GST or GST-EB1. After wash,
bound Pin2/TRF1 was separated on SDS gels, followed by autoradiography. b: GST-EB1 pulldown with HCT116 cell lysate. HCT116 colon
cancer cells were used as the source of endogenous APC and Pin2/TRF1 proteins. Cells were lysed, and incubated with beads containing GST
or GST-EB1. Endogenous APC and Pin2/TRF1 (endo-APC and endo-Pin2/TRF1) were detected by Western blotting. GST-EB1 made a band
just below Pin2/TRF1 as a background of Western blotting. c: Co-immunoprecipitation of EB1 and Pin2/TRF1 in vivo. HeLa cells were co-
transfected with constructs expressing HA-Pin2/TRF1 and FLAG-EB1, then subjected to immunoprecipitation with anti-FLAG mAb, followed
by immunoblotting analysis with anti-FLAG or anti-HA mAb.
Fig. 2. EB1 and Pin2 co-localize in mitotic cells in vivo. GFP-Pin2/TRF1 and RFP-EB1 were co-transfected into HeLa cells. Cells were har-
vested before apoptosis and subjected to £uorescence microscope.
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3.3. EB1 inhibits the ability of Pin2/TRF1 to promote
microtubule polymerization in vitro
We have previously demonstrated that Pin2/TRF1 binds
microtubules and promotes microtubule polymerization in vi-
tro [37]. An obvious question is that EB1 has any e¡ect on
microtubule polymerization activity of Pin2/TRF1. To ad-
dress this question, we performed in vitro microtubule assem-
bly with Pin2 and EB1. Pin2 and EB1 proteins were incubated
with puri¢ed tubulins in microtubule stabilizing bu¡er. The
assembly of microtubules was measured by changes in the
turbidity, as described previously [37,44]. Pin2 alone pro-
moted microtubule polymerization (Fig. 3), as previously re-
ported [37]. Interestingly, EB1 suppressed this ability of Pin2
(Fig. 3). Furthermore, this inhibitory e¡ect depended on the
molar ratio of EB1 with Pin2 (Fig. 3). These results indicate
that EB1 can inhibit the ability of Pin2 to a¡ect microtubule
polymerization in vitro.
3.4. Inhibition of Pin2/TRF1 in ATM-negative cells restores
their defect in response to disruption of the mitotic spindle
Given the in vitro and in vivo interaction between Pin2/
TRF1 and EB1, it is important to examine whether Pin2/
TRF1 a¡ects any microtubule-related function during mitosis
in vivo. A-T (ATM-negative) cells display several cell cycle
defects, including a prominent mitotic defect in response to
microtubule disruption [53^57]. As shown in Fig. 4a, A-T
cells, A-T22IJE-T [50,58], failed to arrest at mitosis in re-
sponse to the microtubule-disrupting agent Nocodazole. In-
stead, they entered apoptosis. Importantly, this phenotype
was fully rescued by stable re-expression of ATM (Fig. 4a),
indicating that the defect is speci¢cally due to loss of ATM.
We have previously demonstrated that Pin2/TRF1 is an ATM
substrate that plays a critical role in mediating ATM regula-
tion [35,36]. Inhibition of Pin2/TRF1 function complements
telomere shortening, the radiosensitivity and G2/M check-
point defect of A-T cells [36]. Moreover, overexpression of
Pin2/TRF1 induces mitotic entry and apoptosis, and this ac-
tivity is signi¢cantly potentiated by Nocodazole treatment or
by ATM mutations [34,35]. These results suggest that Pin2/
TRF1 might be involved in the mitotic spindle defect in A-T
cells.
To address this question, we inhibited the function of en-
dogenous Pin2/TRF1 in A-T cells by stable expression of a
dominant-negative Pin2/TRF1 mutant, GFP-Pin21ÿ316, with
the vector GFP as a control, as described previously [36].
To examine the e¡ect of the mitotic spindle disruption, cells
were treated with Nocodazole or Taxol or control bu¡er for
16 h and the cell cycle pro¢les were determined by £ow cyto-
metry. In the absence of Nocodazole or Taxol, there was no
detectable di¡erence in the cell cycle pro¢le between GFP-
Pin21ÿ316-expressing and vector-transfected cells (Fig. 4b).
However, after Nocodazole treatment, like vector control
A-T cells (Fig. 4a), only about 50% of GFP control cells
were accumulated with the 4n DNA content and V23% of
cells contained the sub-G1 DNA content indicative of apo-
ptosis (Fig. 4b). In sharp contrast, almost all cells expressing
GFP-Pin21ÿ316 were accumulated with the 4n DNA content
(Fig. 4b), as A-T cells that re-expressed ATM (Fig. 4a). Sim-
ilar results were also obtained with Taxol (data not shown).
These results suggest that expression of Pin21ÿ316 in A-T cells
may restore their mitotic spindle defect.
Cells with the mitotic defects have been shown to exit mi-
tosis prematurely without cytokinesis after treatment with mi-
crotubule-disrupting agents; these cells contain the 4n DNA
content with decondensed interphase nuclei or eventually en-
ter apoptosis [59^61]. To further con¢rm that Pin21ÿ316 indeed
restores the mitotic defect in response to microtubule disrup-
tion in A-T cells, we observed the nuclear morphology using
DAPI staining and assayed Cdc2 kinase activity using histone
H1 as a substrate. After Nocodazole treatment, GFP control
cells contained decondensed interphase nuclei, with about
20% cells containing apoptotic nuclei (Fig. 4c), consistent
with the results obtained from £ow cytometrical analysis
(Fig. 4b). Furthermore, the Cdc2 kinase activity was much
lower than that present in mitotic HeLa cells (Fig. 4d). These
results are consistent with the fact that these A-T cells lack the
mitotic spindle checkpoint; they exit mitosis prematurely
without cytokinesis or enter apoptosis after Nocodazole treat-
ment. In contrast, most GFP-Pin21ÿ316-expressing cells con-
tained condensed chromosomes and elevated Cdc2 kinase ac-
tivity similar to that present in mitotic HeLa cells (Fig. 4c,d),
both of which are characteristic of a sustained mitotic block.
These results together suggest that stable expression of the
Pin2 mutant in A-T cells is able to restore their mitotic spindle
defect, demonstrating the functional signi¢cance of the inter-
action between Pin2/TRF1 and the mitotic spindle.
Our results demonstrate the physical and functional inter-
action between Pin2/TRF1 and the microtubule-binding pro-
tein EB1, and also suggest a novel role of Pin2/TRF1 in the
regulation of the mitotic spindle. This is consistent with pre-
vious studies linking telomeres to mitotic progression in other
model systems. For example, mutations or deletion of the
telomeric DNA sequence triggers mitotic entry and apoptosis
in Drosophila [6] or causes a severe delay or block in anaphase
in Tetrahymena [21]. Furthermore, it is also supported by the
cell cycle-speci¢c regulation of Pin2/TRF1 function [30,34,35],
and by the microtubule-binding activity of Pin2/TRF1 [37]. At
present, the signi¢cance of binding of EB1 and Pin2/TRF1 is
unclear, and we can only speculate how expression of the
mutant Pin21ÿ316 is able to restore the mitotic spindle check-
point defect in A-T cells and how Pin2/TRF1 is normally
Fig. 3. EB1 suppresses the ability of Pin2 to promote microtubule
polymerization in vitro. Pin2 was incubated with puri¢ed tubulin
and increasing concentrations of EB1, and the microtubule assembly
was measured by changes in the turbidity. The turbidity in the pres-
ence of Pin2 alone at 10 min is de¢ned as 100%. Indicated concen-
trations of EB1 are relative molar ratio with Pin2.
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involved in the mitotic spindle checkpoint. Since Pin21ÿ316
does not bind microtubules or promote microtubule polymer-
ization [37], its e¡ect on the mitotic spindle checkpoint is
likely via inhibiting endogenous Pin2/TRF1 function in a
dominant-negative manner, as shown previously [32,36].
This is also supported by our ¢ndings that expression of
Pin21ÿ316 signi¢cantly reduces the microtubule-binding activ-
ity of endogenous Pin2/TRF1 in A-T cells [37]. At entry into
mitosis, the breakdown of the nuclear envelope and the in-
crease in Pin2/TRF1 levels, which normally occurs at this time
of the cell cycle, allow Pin2/TRF1 to bind microtubules. This
interaction targets Pin2/TRF1 to the mitotic spindle, where
it may a¡ect the function of microtubules or other proteins
on the mitotic spindle and thereby involve mitotic check-
point regulation. Further experiments are needed to elucidate
how Pin2/TRF1 is involved in the mitotic spindle check-
point.
In summary, we have shown that Pin2/TRF1 interacts with
the microtubule plus end-binding protein EB1 both in vitro
and in vivo. Furthermore, EB1 inhibits the ability of Pin2/
TRF1 to promote microtubule polymerization in vitro. More-
over, inhibition of Pin2/TRF1 mutant in A-T cells is able to
fully restore their mitotic spindle defect in response to micro-
tubule disruption. These results not only con¢rm the speci¢c
interaction between Pin2/TRF1 and the mitotic spindle, as we
demonstrated earlier, but also demonstrate for the ¢rst time a
functional importance of Pin2/TRF1 in the regulation of the
mitotic spindle.
Fig. 4. Inhibition of Pin2/TRF1 rescues the spindle checkpoint defect in A-T cells. a: ATM rescues the spindle checkpoint defect in A-T cells.
A-T cells stably expressing ATM or the control vector were incubated for 16 h in the presence of Nocodazole or control bu¡er (control), fol-
lowed by £ow cytometry. b: GFP-Pin21ÿ316 but not GFP rescues the normal response to Nocodazle in A-T cells. Stable A-T cell lines were in-
cubated with Nocodazole or control bu¡er (control) for 16 h and then subjected to £ow cytometry. c: GFP- but not GFP-Pin21ÿ316-expressing
cells exit mitosis or enter apoptosis after Nocodazole treatment. Stable A-T cell lines were incubated for 16 h in the presence of Nocodazole or
control bu¡er and then stained with DAPI. Arrow points to an apoptotic cell. d: GFP-Pin21ÿ316- but not GFP-expressing cells contain the mi-
totic level of Cdc2 activity after Nocodazole treatment. Stable A-T cell lines were treated with Nocodazole (+) or control bu¡er (3) for 16 h
and cell extracts prepared, followed by assaying Cdc2 kinase activity using histone H1 as a substrate. HeLa cells that were arrested in G1/S or
M by Lovastatin or Nocodazole, respectively, were used as controls.
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